AI-enabled Medical Devices Market Size & Growth Forecast 2027–2036, By Segments (Component, Technology, End Use, Therapeutic Area), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
AI-enabled Medical Devices Market size was around USD 24.13 billion in 2026 and is slated to grow at a 39.27% CAGR from 2027 to 2036, reaching USD 662.42 billion by 2036. The industry revenue for 2027 is assessed at USD 32.49 billion.
Get more details on this report
Request Free Sample ReportAI-enabled Medical Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America captured 54.45% market share in 2026, benefiting from advanced healthcare infrastructure, strong AI adoption, digital health investments, and demand for efficient diagnosis.
- Rising healthcare expenditure, expanding medical infrastructure, government digitalization initiatives, and increasing demand for early diagnosis are accelerating AI-enabled medical device adoption across Asia Pacific.
Segment Momentum
- Software held 52.68% of the market in 2026, reflecting its central role in image analysis, predictive insights, clinical decision support, and automated interpretation. Its ability to expand device functionality supports broader AI integration across healthcare applications.
- Natural language processing is the fastest-growing technology segment, driven by demand for extracting insights from clinical notes, medical reports, and patient records. These capabilities can streamline documentation, improve information retrieval, and support more efficient clinical workflows.
Market Expansion Drivers
- AI-enabled diagnostics.
- Robotics and assisted medical devices.
- Autonomous clinical decision devices.
Leading Market Participants
- Key players in the AI-enabled medical devices market include Siemens Healthineers (Germany), GE HealthCare (USA), Philips (Netherlands), Medtronic (Ireland), Abbott (USA), Canon Medical Systems (Japan), Samsung Medison (South Korea), Boston Scientific (USA), Roche (Switzerland), Johnson & Johnson MedTech (USA).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 24.13 billion
- 2027 Estimated Market Size: USD 32.49 billion
- Projected Market Size: USD 662.42 billion by 2036
- Growth Forecast: 39.27% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Component (Software) | Technology (Machine Learning) | End Use (Hospitals & Clinics) | Therapeutic Area (Radiology)
- Emerging Opportunity Segment: Component (Services) | Technology (Natural Language Processing (NLP)) | End Use (Hospitals & Clinics) | Therapeutic Area (Radiology)
Market Growth Drivers and Industry Trends
AI-enabled diagnostics
The growing integration of artificial intelligence into diagnostic workflows is driving demand for medical devices capable of supporting faster and more accurate detection of diseases and abnormalities. AI-enabled diagnostic systems can assist healthcare professionals in analyzing medical images, identifying clinical patterns, and prioritizing findings that may require further evaluation. Increasing emphasis on early diagnosis, personalized healthcare, and improved clinical efficiency is encouraging healthcare providers to adopt intelligent diagnostic technologies across a wider range of medical applications.
Robotics and assisted medical devices
Advancements in medical robotics and intelligent assisted devices are contributing to market growth by improving precision, consistency, and support across complex clinical procedures. AI-enabled systems can assist healthcare professionals with surgical tasks, rehabilitation, patient monitoring, and other medical activities while enabling more responsive control and workflow optimization. Growing demand for minimally invasive procedures, improved patient outcomes, and technologies that reduce procedural complexity is expected to encourage broader adoption of robotics and AI-assisted medical devices.
Autonomous clinical decision devices
The development of autonomous clinical decision devices is creating new opportunities for AI-enabled medical technologies by enabling systems to analyze clinical information and support decision-making with limited human intervention. These devices can assist with patient assessment, treatment recommendations, monitoring, and other healthcare processes by processing complex medical information in real time. Increasing demand for efficient clinical workflows, continuous patient monitoring, and decision support in resource-constrained healthcare environments is expected to promote the adoption of increasingly autonomous medical technologies.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| AI-enabled diagnostics | 10% | Short term (≤ 2 yrs) | North America; Europe | High | Fast |
| Robotics and assisted medical devices | 8% | Medium term (2–5 yrs) | Europe; Asia Pacific | Medium | Moderate |
| Autonomous clinical decision devices | 6% | Long term (5+ yrs) | North America; Asia Pacific | High | Slow |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America accounted for the largest market share of 54.45% in the AI-enabled medical devices market in 2026, driven by advanced healthcare infrastructure, strong adoption of artificial intelligence, and increasing demand for technology-enabled diagnosis and treatment. Healthcare providers are increasingly integrating AI capabilities into medical devices to improve diagnostic accuracy, streamline clinical workflows, and support personalized patient care. Growing investments in healthcare innovation and the availability of sophisticated digital health infrastructure are further encouraging the deployment of AI-enabled technologies across hospitals and specialized care settings. In addition, increasing demand for early disease detection, efficient clinical decision-making, and automated analysis is supporting the adoption of intelligent medical devices across the region.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to register the fastest growth in the AI-enabled medical devices market, supported by rising healthcare expenditure, expanding medical infrastructure, and increasing adoption of artificial intelligence in clinical applications. Healthcare systems across the region are increasingly seeking advanced technologies that can improve diagnostic efficiency, support physicians, and expand access to quality medical services. Growing prevalence of chronic diseases and rising demand for early and accurate diagnosis are further creating opportunities for AI-powered medical devices. Moreover, government initiatives promoting healthcare digitalization, increasing investments in medical technology, and expanding access to advanced healthcare services are expected to accelerate adoption throughout the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
AI-Integrated Care DeliveryThe U.S. market is prioritizing AI-enabled devices that support clinical decision-making, diagnostics, and personalized treatment while meeting stringent regulatory and evidence requirements. Commercial traction increasingly depends on integration with healthcare workflows, interoperable data platforms, and reimbursement pathways.
Germany 🇩🇪
Regulated Clinical AdoptionGermany is emphasizing clinically validated AI-enabled medical devices that can integrate into hospital workflows and meet European regulatory requirements. Adoption priorities include evidence generation, data interoperability, cybersecurity, and solutions that demonstrate practical value in diagnostics and resource-efficient care delivery.
Japan 🇯🇵
Precision Device InnovationJapan is focusing on AI-enabled medical devices that enhance diagnostic precision, monitoring, and support for an aging patient population. Manufacturers are prioritizing compact, reliable systems with strong clinical validation and integration capabilities, while regulatory alignment remains important for broader deployment across healthcare settings.
South Korea 🇰🇷
Smart Medical HardwareSouth Korea is advancing AI-enabled medical devices through strong integration of artificial intelligence with imaging, diagnostics, and connected healthcare hardware. Market priorities center on hospital-ready solutions, regulatory approvals, and commercialization of locally developed technologies that can support both domestic deployment and international expansion.
France 🇫🇷
Digital Clinical IntegrationFrance is prioritizing AI-enabled devices that strengthen diagnostic workflows and digitally supported patient care within its healthcare system. Commercial development is increasingly shaped by clinical validation, data governance, interoperability, and the ability of device manufacturers to demonstrate measurable improvements in healthcare delivery.
Italy 🇮🇹
Hospital Technology ModernizationItaly is directing attention toward AI-enabled medical devices that can modernize diagnostic and hospital capabilities while fitting established clinical workflows. Manufacturers face opportunities to expand adoption through validated imaging and monitoring applications, interoperable platforms, and solutions that address efficiency pressures across healthcare facilities.
AI-enabled Medical Devices Market Share (%), by Component, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportComponent Segment Analysis: Software (Largest Segment) vs Services (Fastest-Growing Segment)
In 2026, the software component segment accounted for the largest market share of 52.68%, reflecting the central role of software in enabling artificial intelligence capabilities across medical devices and supporting data-driven clinical functions. AI software can facilitate image analysis, pattern recognition, predictive insights, clinical decision support, and automated interpretation of complex medical information. Its integration into medical devices allows manufacturers and healthcare providers to enhance device functionality without relying solely on hardware improvements. Increasing availability of healthcare data, advances in machine learning algorithms, and the growing adoption of connected medical technologies are further supporting software demand. The ability to update, refine, and expand AI-enabled functionality through software also contributes to its importance as AI-enabled medical devices increasingly incorporate intelligent and adaptive capabilities.
The services component segment is projected to grow at the fastest pace, driven by the increasing need for implementation, integration, maintenance, training, validation, and ongoing support associated with AI-enabled medical technologies. Healthcare organizations often require specialized services to integrate AI functionality with existing clinical workflows, information systems, and medical infrastructure. As AI applications become more sophisticated, demand is also increasing for services that support system monitoring, performance optimization, regulatory compliance, and lifecycle management. Healthcare providers may require continued technical assistance to ensure that AI-enabled devices operate effectively in real-world clinical environments. The growing complexity of AI deployment and the need for reliable post-implementation support are therefore creating expanding opportunities for service-based offerings.
Technology Segment Analysis: Machine Learning (Largest Segment) vs Natural Language Processing (NLP) (Fastest-Growing Segment)
The machine learning technology segment accounted for the largest market share of 38.5% in 2026, reflecting its broad applicability across AI-enabled medical devices and its ability to identify patterns from large volumes of clinical and device-generated data. Machine learning can support applications such as medical image interpretation, disease detection, patient monitoring, risk assessment, and predictive analysis, making it relevant across multiple healthcare settings. Its capacity to learn from historical and continuously generated data enables medical technologies to improve analytical capabilities while supporting more automated decision-making processes. Growing adoption of data-driven healthcare and increasing integration of AI into diagnostic and monitoring devices are reinforcing the role of machine learning as a foundational technology.
The natural language processing technology segment is expected to grow at the fastest pace, supported by increasing demand for AI systems capable of understanding, processing, and extracting insights from clinical language. NLP can help transform unstructured information such as clinical notes, medical reports, patient records, and spoken interactions into usable data for healthcare applications. Its integration into AI-enabled medical devices and connected healthcare systems can streamline information retrieval, support clinical documentation, and facilitate more efficient interaction between healthcare professionals and intelligent technologies. As healthcare organizations seek to derive greater value from unstructured clinical information, advances in language understanding and healthcare-specific AI models are expanding the potential applications of NLP across medical environments.
End Use Segment Analysis: Hospitals & Clinics (Largest & Fastest-Growing Segment)
The hospitals and clinics end-use segment accounted for the largest market share of 44.49% in 2026 and is also expected to grow at the fastest pace, reflecting the concentration of diagnostic, monitoring, treatment, and clinical decision-making activities within these healthcare settings. Hospitals and clinics generate substantial volumes of patient and medical data, creating a strong foundation for AI-enabled medical devices that can assist with diagnosis, imaging, monitoring, and treatment-related workflows. AI integration can help healthcare professionals process complex information more efficiently while supporting automation and consistency across clinical procedures. The increasing adoption of advanced diagnostic technologies, connected medical devices, and intelligent clinical systems is further strengthening demand in these settings. As healthcare providers continue to modernize infrastructure and incorporate data-driven technologies into routine care, hospitals and clinics remain a major environment for deployment and expansion.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Component | Software, Hardware, Services | Software | Services |
| Technology | Machine Learning, Natural Language Processing (NLP), Computer Vision, Context-Aware Computing | Machine Learning | Natural Language Processing (NLP) |
| End Use | Hospitals & Clinics, Diagnostic Centers, Ambulatory Surgical Centers (ASCs), Home Care Settings, Others | Hospitals & Clinics | Hospitals & Clinics |
| Therapeutic Area | Cardiology, Neurology, Radiology, Oncology, Mental and Behavioral Health, Ophthalmology, Others | Radiology | Radiology |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
Market success for AI-driven clinical tools depends on balancing processing speed with stringent data security and workflow integration. While edge computing addresses privacy concerns through localized processing, devices must still demonstrate rigorous clinical validation to mitigate algorithmic bias across diverse patient populations. Ultimately, low diagnostic latency and seamless EHR interoperability are critical to driving operational value and supporting clinicians at the point of care.
Key companies in the AI-enabled medical devices market:
- Siemens Healthineers (Germany)
- GE HealthCare (USA)
- Philips (Netherlands)
- Medtronic (Ireland)
- Abbott (USA)
- Canon Medical Systems (Japan)
- Samsung Medison (South Korea)
- Boston Scientific (USA)
- Roche (Switzerland)
- Johnson & Johnson MedTech (USA)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Siemens Healthineers (Germany) | |||||||
| GE HealthCare (USA) | |||||||
| Philips (Netherlands) | |||||||
| Medtronic (Ireland) | |||||||
| Abbott (USA) | |||||||
| Canon Medical Systems (Japan) | |||||||
| Samsung Medison (South Korea) | |||||||
| Boston Scientific (USA) | |||||||
| Roche (Switzerland) | |||||||
| Johnson & Johnson MedTech (USA) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| GE HealthCare | February 2025 | GE HealthCare expanded its AI-enabled medical technology portfolio through 27 FDA-approved devices, strategic acquisitions, and health system partnerships. These combined initiatives strengthen the company's technical capabilities across various clinical applications and reinforce its competitive position within the broader AI-driven healthcare technology sector. |
| Abbott | September 2024 | Abbott established a strategic partnership with iCardio.ai to jointly develop artificial intelligence imaging solutions aimed at enhancing cardiovascular diagnostics. The collaboration combines Abbott's market reach with iCardio.ai's proprietary technology talent, advancing the integration of artificial intelligence into ultrasound diagnostic equipment and clinical workflows. |
| Siemens Healthineers | May 2024 | Siemens Healthineers integrated new artificial intelligence-powered cardiology applications into its Acuson Sequoia ultrasound system alongside a 4D transesophageal transducer. This technological expansion supports a versatile shared service model, enabling a single clinical system to efficiently execute radiology, obstetrics, gynecology, and cardiology diagnostic examinations. |
| GE HealthCare | March 2024 | GE HealthCare introduced a broad portfolio of AI-enabled medical devices and digital solutions at HIMSS 2024, featuring AI-guided ultrasound, diagnostic imaging, patient monitoring, and workflow technologies. The company additionally established an AI partnership with Mass General Brigham to extend its technological capabilities and healthcare integration footprint. |
| Philips | February 2024 | Philips commercialized the AI-enabled CT 5300 system at ECR 2024 to enhance diagnostic confidence, streamline department workflows, and elevate patient care across cardiac, interventional, and screening applications. The system incorporates artificial intelligence across key functional aspects to reduce manual operational burdens for technicians and radiologists. |
| Paige | October 2023 | Paige Lymph Node, an artificial intelligence-based software tool designed for detecting breast cancer metastases in lymph nodes, was granted FDA Breakthrough Device Designation. The regulatory milestone recognizes the technology's potential to address critical clinical bottlenecks in pathologic assessments, which are essential for patient outcome prediction and treatment planning. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
AI-enabled Medical Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Clinical Workflow Stage | Screening & Detection, Diagnosis & Interpretation, Treatment Planning, Intervention & Treatment, Monitoring & Follow-up |
| AI Deployment Model | On-device/Edge AI, Cloud-based AI, Hybrid AI |
| Procurement Model | Direct Capital Purchase, Subscription/Software-as-a-Service, Managed Service/AI-as-a-Service, Usage-based Procurement |
AI-enabled Medical Devices Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| AI Medical Device Commercialization Pathways |
|
| Clinical Adoption & Workflow Integration |
|
| Post-Market AI Governance & Monitoring |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
What is the overall size of the AI-enabled medical devices market?
What is the anticipated CAGR of the AI-enabled medical devices industry?
How is AI-driven diagnostics accelerating adoption of intelligent medical devices?
How are robotics and autonomous capabilities reshaping AI-enabled medical device deployment?
Why does software account for the largest share of the AI-enabled medical devices market?
How is natural language processing creating new opportunities in the AI-enabled medical devices market?
How does North America maintain its leadership in the AI-enabled medical devices market?
What is accelerating AI-enabled medical device adoption across Asia Pacific?
Which organizations are considered leaders in the AI-enabled medical devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook